SynthesisEndocrine2026

Once-weekly somapacitan vs. daily norditropin in GHD: a systematic review and meta-analysis of efficacy and safety in children and adults.

Sarah Azhar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.